Industry: Medical Devices & Consumables
Published Date: 2024-04-17
Pages: 146 Pages
Report ld: 2700526
Request Sample
Customized Report
Cardiopulmonary Bypass Equipment Market Size(US$)

CAGR 2024-2030
9.7%
Market Size,2030
USD 810.9
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
The global Cardiopulmonary Bypass Equipment market size was US$ 421 million in 2023 and is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 9.7% during the forecast period 2024-2030.
Global Cardiopulmonary Bypass Equipment key players include Sorin, MAQUET, Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%.
North America is the largest market, with a share over 40%, followed by Europe and Asia (ex. China), both have a share over 40%.
In terms of product, Single Roller Pump HLM is the largest segment, with a share over 65%. And in terms of application, the largest application is Cardiac Surgery, followed by Acute Respiratory Failure Treatment, Lung Transplant Operation, etc.
In terms of sales (consumption) side, this report focuses on the sales of Cardiopulmonary Bypass Equipment by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Cardiopulmonary Bypass Equipment market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Cardiopulmonary Bypass Equipment market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Cardiopulmonary Bypass Equipment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Cardiopulmonary Bypass Equipment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiopulmonary Bypass Equipment sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Cardiopulmonary Bypass Equipment Definition
1.2 Market by Type
1.2.1 Global Cardiopulmonary Bypass Equipment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Single Roller Pump Cardiopulmonary Bypass Equipment
1.2.3 Double Roller Pump Cardiopulmonary Bypass Equipment
1.3 Market Segment by Application
1.3.1 Global Cardiopulmonary Bypass Equipment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Cardiopulmonary Bypass Equipment Sales
2.1 Global Cardiopulmonary Bypass Equipment Revenue Estimates and Forecasts 2019-2030
2.2 Global Cardiopulmonary Bypass Equipment Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Cardiopulmonary Bypass Equipment Revenue by Region
2.3.1 Global Cardiopulmonary Bypass Equipment Revenue by Region (2019-2024)
2.3.2 Global Cardiopulmonary Bypass Equipment Revenue by Region (2025-2030)
2.4 Global Cardiopulmonary Bypass Equipment Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Cardiopulmonary Bypass Equipment Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Cardiopulmonary Bypass Equipment Sales Quantity by Region
2.6.1 Global Cardiopulmonary Bypass Equipment Sales Quantity by Region (2019-2024)
2.6.2 Global Cardiopulmonary Bypass Equipment Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Cardiopulmonary Bypass Equipment Sales Quantity by Manufacturers
3.1.1 Global Cardiopulmonary Bypass Equipment Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Cardiopulmonary Bypass Equipment Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Cardiopulmonary Bypass Equipment Sales in 2023
3.2 Global Cardiopulmonary Bypass Equipment Revenue by Manufacturers
3.2.1 Global Cardiopulmonary Bypass Equipment Revenue by Manufacturers (2019-2024)
3.2.2 Global Cardiopulmonary Bypass Equipment Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Cardiopulmonary Bypass Equipment Revenue in 2023
3.3 Global Cardiopulmonary Bypass Equipment Sales Price by Manufacturers
3.4 Global Key Players of Cardiopulmonary Bypass Equipment, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cardiopulmonary Bypass Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Product Offered and Application
3.8 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Cardiopulmonary Bypass Equipment Sales Quantity by Type
4.1.1 Global Cardiopulmonary Bypass Equipment Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Cardiopulmonary Bypass Equipment Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Cardiopulmonary Bypass Equipment Sales Quantity Market Share by Type (2019-2030)
4.2 Global Cardiopulmonary Bypass Equipment Revenue by Type
4.2.1 Global Cardiopulmonary Bypass Equipment Historical Revenue by Type (2019-2024)
4.2.2 Global Cardiopulmonary Bypass Equipment Forecasted Revenue by Type (2025-2030)
4.2.3 Global Cardiopulmonary Bypass Equipment Revenue Market Share by Type (2019-2030)
4.3 Global Cardiopulmonary Bypass Equipment Price by Type
4.3.1 Global Cardiopulmonary Bypass Equipment Price by Type (2019-2024)
4.3.2 Global Cardiopulmonary Bypass Equipment Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Cardiopulmonary Bypass Equipment Sales Quantity by Application
5.1.1 Global Cardiopulmonary Bypass Equipment Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Cardiopulmonary Bypass Equipment Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Cardiopulmonary Bypass Equipment Sales Quantity Market Share by Application (2019-2030)
5.2 Global Cardiopulmonary Bypass Equipment Revenue by Application
5.2.1 Global Cardiopulmonary Bypass Equipment Historical Revenue by Application (2019-2024)
5.2.2 Global Cardiopulmonary Bypass Equipment Forecasted Revenue by Application (2025-2030)
5.2.3 Global Cardiopulmonary Bypass Equipment Revenue Market Share by Application (2019-2030)
5.3 Global Cardiopulmonary Bypass Equipment Price by Application
5.3.1 Global Cardiopulmonary Bypass Equipment Price by Application (2019-2024)
5.3.2 Global Cardiopulmonary Bypass Equipment Price Forecast by Application (2025-2030)
6 North America
6.1 North America Cardiopulmonary Bypass Equipment Sales by Company
6.1.1 North America Cardiopulmonary Bypass Equipment Revenue by Company (2019-2024)
6.1.2 North America Cardiopulmonary Bypass Equipment Sales Quantity by Company (2019-2024)
6.2 North America Cardiopulmonary Bypass Equipment Market Size by Type
6.2.1 North America Cardiopulmonary Bypass Equipment Sales Quantity by Type (2019-2030)
6.2.2 North America Cardiopulmonary Bypass Equipment Revenue by Type (2019-2030)
6.3 North America Cardiopulmonary Bypass Equipment Market Size by Application
6.3.1 North America Cardiopulmonary Bypass Equipment Sales Quantity by Application (2019-2030)
6.3.2 North America Cardiopulmonary Bypass Equipment Revenue by Application (2019-2030)
6.4 North America Cardiopulmonary Bypass Equipment Market Size by Country
6.4.1 North America Cardiopulmonary Bypass Equipment Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cardiopulmonary Bypass Equipment Revenue by Country (2019-2030)
6.4.3 North America Cardiopulmonary Bypass Equipment Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cardiopulmonary Bypass Equipment Sales by Company
7.1.1 Europe Cardiopulmonary Bypass Equipment Sales Quantity by Company (2019-2024)
7.1.2 Europe Cardiopulmonary Bypass Equipment Revenue by Company (2019-2024)
7.2 Europe Cardiopulmonary Bypass Equipment Market Size by Type
7.2.1 Europe Cardiopulmonary Bypass Equipment Sales Quantity by Type (2019-2030)
7.2.2 Europe Cardiopulmonary Bypass Equipment Revenue by Type (2019-2030)
7.3 Europe Cardiopulmonary Bypass Equipment Market Size by Application
7.3.1 Europe Cardiopulmonary Bypass Equipment Sales Quantity by Application (2019-2030)
7.3.2 Europe Cardiopulmonary Bypass Equipment Revenue by Application (2019-2030)
7.4 Europe Cardiopulmonary Bypass Equipment Market Size by Country
7.4.1 Europe Cardiopulmonary Bypass Equipment Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cardiopulmonary Bypass Equipment Revenue by Country (2019-2030)
7.4.3 Europe Cardiopulmonary Bypass Equipment Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Cardiopulmonary Bypass Equipment Sales by Company
8.1.1 China Cardiopulmonary Bypass Equipment Sales Quantity by Company (2019-2024)
8.1.2 China Cardiopulmonary Bypass Equipment Revenue by Company (2019-2024)
8.2 China Cardiopulmonary Bypass Equipment Market Size by Type
8.2.1 China Cardiopulmonary Bypass Equipment Sales Quantity by Type (2019-2030)
8.2.2 China Cardiopulmonary Bypass Equipment Revenue by Type (2019-2030)
8.3 China Cardiopulmonary Bypass Equipment Market Size by Application
8.3.1 China Cardiopulmonary Bypass Equipment Sales Quantity by Application (2019-2030)
8.3.2 China Cardiopulmonary Bypass Equipment Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Cardiopulmonary Bypass Equipment Sales by Company
9.1.1 APAC Cardiopulmonary Bypass Equipment Sales Quantity by Company (2019-2024)
9.1.2 APAC Cardiopulmonary Bypass Equipment Revenue by Company (2019-2024)
9.2 APAC Cardiopulmonary Bypass Equipment Market Size by Type
9.2.1 APAC Cardiopulmonary Bypass Equipment Sales Quantity by Type (2019-2030)
9.2.2 APAC Cardiopulmonary Bypass Equipment Revenue by Type (2019-2030)
9.3 APAC Cardiopulmonary Bypass Equipment Market Size by Application
9.3.1 APAC Cardiopulmonary Bypass Equipment Sales Quantity by Application (2019-2030)
9.3.2 APAC Cardiopulmonary Bypass Equipment Revenue by Application (2019-2030)
9.4 APAC Cardiopulmonary Bypass Equipment Market Size by Region
9.4.1 APAC Cardiopulmonary Bypass Equipment Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Cardiopulmonary Bypass Equipment Revenue by Region (2019-2030)
9.4.3 APAC Cardiopulmonary Bypass Equipment Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Sales by Company
10.1.1 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Market Size by Type
10.2.1 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Market Size by Application
10.3.1 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Market Size by Country
10.4.1 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Cardiopulmonary Bypass Equipment Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sorin
11.1.1 Sorin Company Information
11.1.2 Sorin Overview
11.1.3 Sorin Cardiopulmonary Bypass Equipment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Sorin Cardiopulmonary Bypass Equipment Products and Services
11.1.5 Sorin Cardiopulmonary Bypass Equipment SWOT Analysis
11.1.6 Sorin Recent Developments
11.2 MAQUET
11.2.1 MAQUET Company Information
11.2.2 MAQUET Overview
11.2.3 MAQUET Cardiopulmonary Bypass Equipment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 MAQUET Cardiopulmonary Bypass Equipment Products and Services
11.2.5 MAQUET Cardiopulmonary Bypass Equipment SWOT Analysis
11.2.6 MAQUET Recent Developments
11.3 Medtronic
11.3.1 Medtronic Company Information
11.3.2 Medtronic Overview
11.3.3 Medtronic Cardiopulmonary Bypass Equipment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Medtronic Cardiopulmonary Bypass Equipment Products and Services
11.3.5 Medtronic Cardiopulmonary Bypass Equipment SWOT Analysis
11.3.6 Medtronic Recent Developments
11.4 Terumo
11.4.1 Terumo Company Information
11.4.2 Terumo Overview
11.4.3 Terumo Cardiopulmonary Bypass Equipment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Terumo Cardiopulmonary Bypass Equipment Products and Services
11.4.5 Terumo Cardiopulmonary Bypass Equipment SWOT Analysis
11.4.6 Terumo Recent Developments
11.5 Braile Biomedica
11.5.1 Braile Biomedica Company Information
11.5.2 Braile Biomedica Overview
11.5.3 Braile Biomedica Cardiopulmonary Bypass Equipment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Braile Biomedica Cardiopulmonary Bypass Equipment Products and Services
11.5.5 Braile Biomedica Cardiopulmonary Bypass Equipment SWOT Analysis
11.5.6 Braile Biomedica Recent Developments
11.6 Tianjin Medical
11.6.1 Tianjin Medical Company Information
11.6.2 Tianjin Medical Overview
11.6.3 Tianjin Medical Cardiopulmonary Bypass Equipment Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Tianjin Medical Cardiopulmonary Bypass Equipment Products and Services
11.6.5 Tianjin Medical Cardiopulmonary Bypass Equipment SWOT Analysis
11.6.6 Tianjin Medical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Cardiopulmonary Bypass Equipment Value Chain Analysis
12.2 Cardiopulmonary Bypass Equipment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cardiopulmonary Bypass Equipment Production Mode & Process
12.4 Cardiopulmonary Bypass Equipment Sales and Marketing
12.4.1 Cardiopulmonary Bypass Equipment Sales Channels
12.4.2 Cardiopulmonary Bypass Equipment Distributors
12.5 Cardiopulmonary Bypass Equipment Customers
13 Market Dynamics
13.1 Cardiopulmonary Bypass Equipment Industry Trends
13.2 Cardiopulmonary Bypass Equipment Market Drivers
13.3 Cardiopulmonary Bypass Equipment Market Challenges
13.4 Cardiopulmonary Bypass Equipment Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 550 million in 2025 to US$ 1042 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-11
Pages: 139
USD 4900.00
(Single User License)
The global Cardiopulmonary Bypass Equipment market size was US$ 550 million in 2025 and is forecast to reach a readjusted size of US$ 1042 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published Date: 2026-07-11
Pages: 128
USD 4250.00
(Single User License)
The global Cardiopulmonary Bypass Equipment market was valued at US$ 550 million in 2025 and is anticipated to reach US$ 1042 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 114
USD 2900.00
(Single User License)
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 550 million in 2025 and is projected to reach US$ 1042 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 132
USD 3950.00
(Single User License)
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 506 million in 2024 to US$ 959 million by 2031, at a CAGR of 9.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 135
USD 4900.00
(Single User License)
In 2024, the global market size of Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million and is forecast to reach approximately US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 123
USD 5900.00
(Single User License)
The global Cardiopulmonary Bypass Equipment market size was US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 77
USD 4250.00
(Single User License)
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 109
USD 3950.00
(Single User License)
The global market for Cardiopulmonary Bypass Equipment was valued at US$ 506 million in the year 2024 and is projected to reach a revised size of US$ 959 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published Date: 2025-01-16
Pages: 83
USD 2900.00
(Single User License)
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published Date: 2024-04-16
Pages: 123
USD 5900.00
(Single User License)
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 550 million in 2025 to US$ 1042 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-11
Pages: 139
The global Cardiopulmonary Bypass Equipment market size was US$ 550 million in 2025 and is forecast to reach a readjusted size of US$ 1042 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published: 2026-07-11
Pages: 128
The global Cardiopulmonary Bypass Equipment market was valued at US$ 550 million in 2025 and is anticipated to reach US$ 1042 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-07-11
Pages: 114
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 550 million in 2025 and is projected to reach US$ 1042 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-07-11
Pages: 132
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 506 million in 2024 to US$ 959 million by 2031, at a CAGR of 9.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 135
In 2024, the global market size of Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million and is forecast to reach approximately US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 123
The global Cardiopulmonary Bypass Equipment market size was US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 77
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 109
The global market for Cardiopulmonary Bypass Equipment was valued at US$ 506 million in the year 2024 and is projected to reach a revised size of US$ 959 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published: 2025-01-16
Pages: 83
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published: 2024-04-16
Pages: 123
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now